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Group 1 Group 2 p
General population (n) 511 266
TIMI major (%) 0.2 2.3 <0.01
TIMI minor (%) 2.0 3.4 0.22
MACCE (%) 3.5 3.4 0.9
Propensity-matched population (n) 229 229
TIMI major (%) 0 2.6 <0.05
TIMI minor (%) 1.3 3.9 0.79
MACCE (%) 4.4 2.6 0.44
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Active Versus Passive Anchoring Vascular Closure Devices: A Safety and
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Background: We evaluate the prevalence of complications and failure rates between
the most commonly used “active” anchoring vascular closure device (VCD),
AngioSeal and the “passive” anchoring VCD, Mynx, in all-comers undergoing
percutaneous coronary intervention (PCI).
Methods: A total of 4,074 patients between 2008-2014, representing an era when both
devices were available, were included. 32% were acute coronary syndromes (37%
STEMI). VCD choice was at the operator’s discretion and included AngioSeal
(n¼2910) or Mynx (1,164). Cardiogenic shock or patients receiving intra-aortic
balloon pumps were excluded. Safety was assessed by vascular complications deﬁned
as either vascular injury (perforation, dissection, acute limb ischemia, arteriovenous
ﬁstula, pseudoaneurysm with thrombin injection, or surgical repair) or access-site
bleed (hemoglobin drop >3 g/dL requiring transfusion, retroperitoneal bleed, or he-
matoma >5cm, or the composite of both. Efﬁcacy was evaluated by device failure
deﬁned as inability to achieve immediate hemostasis, or additional hemostatic
mechanisms require. Outcomes at 30-days were evaluated.
Results: Groups (AngioSeal vs. Mynx) were fairly balanced with regards to bleeding
risk factors of gender (male, 65% vs. 66%), body mass index (306 vs. 307), heart
failure class III/IV (5% vs. 6%), chronic kidney disease (15% vs. 17%), use of
glycoprotein IIb/IIIa inhibitor (5% vs. 4%) or bivalirudin (86% vs. 88%), all p >0.5.
The AngioSeal group was slightly younger (6412 vs. 6512, p < 0.001) with less
peripheral arterial disease (11.3% vs. 13.9%, p ¼0.03), and increased 7F sheath use
compared with Mynx (59% vs. 22%, p < 0.001). Safety and efﬁcacy outcomes were
similar between groups (table).
Conclusions: AngioSeal and Mynx appear to be equally safe and efﬁcacious VCDs
following PCI. The passive anchoring system may prove desirable as no intra-arterial
anchor remains upon device removal.Outcomes
p valueAngioSeal (n¼2,910) Mynx (n¼1,164)
Safety
Vascular injury 0.30% 0.80% 0.09
Access-site bleed 1.90% 1.40% 0.8
Composite safety 2.30% 1.50% 0.6
Efﬁcacy
Device failure 7.50% 8.70% 0.4TCT-845
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Background: Radial approach (RA) has been shown to reduce access-related
bleedings as compared to femoral approach (FA). However, although the risk of
femoral bleeding can be reduced with the adoption of vascular closure devices (VCD),
there are few data about the comparison of RA and FA with VCD, particularly in
patients at high risk of bleeding such as those undergoing primary percutaneous
coronary intervention (pPCI). The FemoSeal (St.Jude Medical,MN,USA) is a
sandwich type, fully resorbable VCD that has been associated with a low rate of
access-site bleeding and vascular complications. Aim of this study was to compare the
incidence of bleedings, deﬁned according to the Thrombolysis in Myocardial
Infarction (TIMI) criteria, and of major adverse cardiac and cerebrovascular events
(MACCE) in a population of patients undergoing primary angioplasty through RA or
FA with systematic closure by FemoSeal.
Methods:We included in this retrospective registry 777 patients who underwent pPCI
at two high-volume Centers from years 2010 to 2013. Exclusion criteria were the
implantation of intra-aortic balloon pump and the achievement of femoral hemostasis
by other means than the FemoSeal. The study population was divided in RA pa-
tients, enrolled in Center A (Group 1, n¼511) and FA patients, enrolled in Center BB246 JACC Vol 64/11/Suppl B j September 13–17, 2014 j TCT A(Group 2, n¼266). We performed multivariate analysis and propensity-score matching
in order to adjust for clinical and procedural confounders.
Results: Main results of the study are provided in the Table. At multivariate analysis,
the following predictors of bleeding were identiﬁed: FA (OR 3.2, 95% C.I. 1.3-7.5),
use of Gp IIb/IIIa blockers (OR 3.6, 95% C.I. 1.5-8.7) and heart rate at presentation
(OR 1.04, 95% C.I. 1.02-1.07).
Conclusions: In primary PCI the rate of TIMI major bleedings was higher in FA with
closure by FemoSeal as compared to RA, whereas the rates of minor bleedings and
of MACCE were similar.TCT-846
Radial-to-femoral access crossover is not associated with adverse outcomes in the
setting of primary percutaneous coronary intervention
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Background: We aimed to describe the impact of the vascular access used when
patients are treated with primary percutaneous coronary intervention (PPCI) and to
assess whether this translates into differences in angiographic outcomes.
Methods: ST-elevation myocardial infarction (STEMI) patients undergoing PPCI
were divided into three groups: successful radial access (RA), successful femoral
access (FA) and Crossover (failed RA with need for bailout FA) groups. Vascular
access-related time (VART) was deﬁned as the delay in PPCI that can be attributed to
vascular access-related issues. Study endpoint was the ﬁnal corrected TIMI frame
count (CTFC). Multivariable analysis was used to identify predictors of RA failure
(RAF: FA+Crossover).
Results: We included 241 patients (RA n¼172, FA n¼49, Crossover n¼20).
Mean VART was longer in Crossover (10.3 (8.8-12.4) min), relative to RA (4.1
(3.2-5.5) min) and FA (4.6 (3.4-8.4) min, p< 0.001). A similar situation was
found for time-to-ﬁrst-device (Crossover: 22.5 (20.3-32.0) min; RA: 15.0 (12.0-
19.8) min; FA: 17.9 (13.5-22.3) min; p< 0.001) and total procedure time
(Crossover: 60.3 (51.6-71.5) min; RA: 46.8 (38.1-59.7) min; FA: 52.3 (41.9-
74.7) min; p< 0.001). No differences in CTFC were observed (Crossover: 26
(18-32) frames; RA: 24 (18-32) frames; FA: 25 (16-34) frames; p¼0.625). Killip
class IV (OR 3.628, 95% CI: 1.098-11.981, p¼0.035), cardiopulmonary resus-
citation prior to arrival (OR 3.572, 95% CI: 1.028-12.407, p¼0.045) and
glomerular ﬁltration rate (OR 0.861, 95% CI: 0.758-0.978, p¼0.021) were in-
dependent predictors of RAF.
Conclusions: In the setting of PPCI, radial-to-femoral access crossover can lead to
VART delays that do not impact angiographic outcomes, in comparison with suc-
cessful RA. Killip class IV, cardiopulmonary resuscitation prior to arrival and
impaired renal function are independent predictors of RAF in STEMI patients un-
dergoing PPCI.
TCT-847
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Background: Patients undergoing primary percutaneous coronary intervention (PCI)
for ST-elevation myocardial infarction (STEMI) are at high risk of femoral vascular
complications (VC). In spite of the growing use of radial approach, femoral remains
the most common in primary PCI. The use of femoral vascular closure devices
(VCDs) has expanded in recent years despite previous controversial trials. Angio-
Seal is a collagen-based plug/anchor intravascular device and Exo-Seal is an
extravascular polyglykolacid plug. Objective: to evaluate safety and efﬁcacy, and to
compare these VCDs in primary PCI.bstracts/Vascular Access and Intervention - Femoral (includes closure devices)
